Clinical Trials Logo

Clinical Trial Summary

Maintaining the condylar position after bilateral sagittal split ramus osteotomy (BSSO) is one of the most important aspects in terms of condylar function ,.An altered condylar position can cause internal derangement of the joint, loss of the mandibular angle, increased risk of relapse, condyle sagging, and impaired masticatory function.

In previous years, a great deal of attention has been paid to maintaining the preoperative condylar position during orthognathic surgery. Numerous condylar positioning methods have been reported and could be divided into manual/empirical methods, conventional methods , navigation, and sonographic monitoring, Computer guided methods which is more accurate than other methods


Clinical Trial Description

unpredictable condylar position after orthognathic surgery, will lead to malocclusion, derangement of the condylar surface, condylar resorption, condylar sag, distraction of the condyles from the fosse. In previous years, several authors had been adopted several techniques to maintain the preoperative condylar position during orthognathic surgery. Numerous condylar positioning methods have been reported which could be divided into conventional techniques (manual maneuvers or aiding tools), Extra and intra oral navigational techniques , surgeons had been utilized these techniques in condylar repositiong after BSSO but it was time and effort consuming and sometimes it was inaccurate. the aim for conducting the research is accurate positioning of condyle three dimensionally to minimize effort and operating time of surgery . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03983265
Study type Interventional
Source Cairo University
Contact yara mamdouh mustafa, BDS
Phone 01002955632
Email yara.mustafa@dentistry.cu.edu.eg
Status Recruiting
Phase N/A
Start date November 20, 2018
Completion date January 2020

See also
  Status Clinical Trial Phase
Withdrawn NCT02298699 - Biomarker for Sly Disease (MPS VII) (BioSly)
Withdrawn NCT02298673 - Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)
Terminated NCT03651245 - European Alpha-Mannosidosis Participant